Literature DB >> 18157525

Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes.

Natasa Djordjevic1, Roza Ghotbi, Leif Bertilsson, Slobodan Jankovic, Eleni Aklillu.   

Abstract

OBJECTIVES: To investigate the influence of coffee consumption on CYP1A2 enzyme activity controlling for the effects of smoking and oral contraceptive (OC) use among Serbs and Swedes and to compare CYP1A2 activity between the two populations.
METHODS: Data on oral contraceptive use, habitual coffee consumption and smoking habits were obtained from 100 Serbian and 149 Swedish healthy volunteers using a detailed questionnaire. CYP1A2 activity was estimated by plasma paraxanthine/caffeine (17X/137X) ratio analysed by reversed-phase HPLC after oral administration of 100 mg caffeine.
RESULTS: Daily consumption of at least three cups of coffee significantly increased CYP1A2 enzyme activity in both Serbs (P=0.0002) and Swedes (P<0.0001). Among non-smokers and non-OC users, heavy coffee consumption significantly increased CYP1A2 activity in Serbs (mean difference 0.11; 95% CI of the mean difference 0.04, 0.18; P=0.003) and Swedes (mean difference 0.07; 95% CI of the mean difference 0.01, 0.12; P=0.02). Significantly higher 17X/137X ratio was detected in Serbian smokers compared to non-smokers. There was no significant gender difference in CYP1A2 activity in Serbs. Controlling for the effect of smoking, heavy coffee consumption habit and oral contraceptive use, significantly lower 17X/137X ratio was observed in Serbs than in Swedes (P=0.0003).
CONCLUSIONS: Habitual heavy coffee consumption increases CYP1A2 activity. Polycyclic aromatic hydrocarbons formed during roasting of coffee beans might partly be responsible for this effect. The reason for the observed lower CYP1A2 activity in Serbs as compared to Swedes remains to be investigated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18157525     DOI: 10.1007/s00228-007-0438-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  26 in total

1.  Coffee, tea, mate, methylxanthines and methylglyoxal. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 27 February to 6 March 1990.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  1991

Review 2.  Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.

Authors:  Mei-Ling Chen
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.

Authors:  Roza Ghotbi; Magnus Christensen; Hyung-Keun Roh; Magnus Ingelman-Sundberg; Eleni Aklillu; Leif Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2007-03-17       Impact factor: 2.953

Review 4.  Enzyme induction in the cytochrome P-450 system.

Authors:  A B Okey
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

5.  Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: lack of association with the Ah locus.

Authors:  E O Ayalogu; J Snelling; D F Lewis; S Talwar; M N Clifford; C Ioannides
Journal:  Biochim Biophys Acta       Date:  1995-10-17

6.  A study of gender-based cytochrome P4501A2 variability: a possible mechanism for the male excess of bladder cancer.

Authors:  E P Horn; M A Tucker; G Lambert; D Silverman; D Zametkin; R Sinha; T Hartge; M T Landi; N E Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1995 Jul-Aug       Impact factor: 4.254

7.  Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2.

Authors:  Xing-Mei Han; Dong-Sheng Ouyang; Xiao-Ping Chen; Yan Shu; Chang-Hong Jiang; Zhi-Rong Tan; Hong-Hao Zhou
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335

8.  Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities.

Authors:  M V Relling; J S Lin; G D Ayers; W E Evans
Journal:  Clin Pharmacol Ther       Date:  1992-12       Impact factor: 6.875

9.  Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.

Authors:  Eleni Aklillu; Juan Antonio Carrillo; Eyasu Makonnen; Karin Hellman; Marià Pitarque; Leif Bertilsson; Magnus Ingelman-Sundberg
Journal:  Mol Pharmacol       Date:  2003-09       Impact factor: 4.436

10.  Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine.

Authors:  B B Rasmussen; J Maënpää; O Pelkonen; S Loft; H E Poulsen; J Lykkesfeldt; K Brøsen
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

View more
  24 in total

1.  Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2.

Authors:  David R Plowchalk; Karen Rowland Yeo
Journal:  Eur J Clin Pharmacol       Date:  2012-01-19       Impact factor: 2.953

2.  Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 -163C>A polymorphism.

Authors:  Natasa Djordjevic; Roza Ghotbi; Slobodan Jankovic; Eleni Aklillu
Journal:  Eur J Clin Pharmacol       Date:  2010-07       Impact factor: 2.953

3.  CYP2C19 activity comparison between Swedes and Koreans: effect of genotype, sex, oral contraceptive use, and smoking.

Authors:  Margareta Ramsjö; Eleni Aklillu; Lilleba Bohman; Magnus Ingelman-Sundberg; Hyung-Keun Roh; Leif Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2010-05-25       Impact factor: 2.953

4.  A limited sampling strategy based on maximum a posteriori Bayesian estimation for a five-probe phenotyping cocktail.

Authors:  Thu Thuy Nguyen; Henri Bénech; Alain Pruvost; Natacha Lenuzza
Journal:  Eur J Clin Pharmacol       Date:  2016-01       Impact factor: 2.953

Review 5.  Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes.

Authors:  Yeo-Jung Kwon; Sangyun Shin; Young-Jin Chun
Journal:  Arch Pharm Res       Date:  2021-01-23       Impact factor: 4.946

6.  Caffeine, coffee, and tea intake and urinary estrogens and estrogen metabolites in premenopausal women.

Authors:  Julia S Sisti; Susan E Hankinson; Neil E Caporaso; Fangyi Gu; Rulla M Tamimi; Bernard Rosner; Xia Xu; Regina Ziegler; A Heather Eliassen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-10       Impact factor: 4.254

7.  PharmGKB summary: very important pharmacogene information for CYP1A2.

Authors:  Caroline F Thorn; Eleni Aklillu; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2012-01       Impact factor: 2.089

Review 8.  Blood pressure in relation to coffee and caffeine consumption.

Authors:  Idris Guessous; Chin B Eap; Murielle Bochud
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

9.  Coffee consumption and risk of hypertension: a dose-response meta-analysis of prospective studies.

Authors:  Lanfranco D'Elia; Ersilia La Fata; Ferruccio Galletti; Luca Scalfi; Pasquale Strazzullo
Journal:  Eur J Nutr       Date:  2017-12-08       Impact factor: 5.614

10.  Pre-pregnancy caffeine and caffeinated beverage intake and risk of spontaneous abortion.

Authors:  Audrey J Gaskins; Janet W Rich-Edwards; Paige L Williams; Thomas L Toth; Stacey A Missmer; Jorge E Chavarro
Journal:  Eur J Nutr       Date:  2016-08-29       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.